CN Stock MarketDetailed Quotes

301230 Pharmaresources

Watchlist
  • 29.93
  • +0.36+1.22%
Market Closed Jun 7 15:00 CST
3.22BMarket Cap123.68P/E (TTM)

Pharmaresources Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
7.69%130.73M
2.26%489.72M
10.56%367.21M
15.44%237.66M
16.37%121.39M
6.84%478.88M
12.58%332.13M
8.67%205.87M
33.00%104.31M
58.39%448.21M
Operating revenue
7.69%130.73M
2.26%489.72M
10.56%367.21M
15.44%237.66M
16.37%121.39M
6.84%478.88M
12.58%332.13M
8.67%205.87M
33.00%104.31M
58.39%448.21M
Other operating revenue
----
36.64%9.24M
----
427.56%8.54M
----
281.02%6.76M
----
170.43%1.62M
----
-60.46%1.77M
Total operating cost
29.49%135.33M
9.94%450.09M
9.86%319.39M
9.98%200.33M
13.03%104.5M
13.31%409.4M
18.30%290.74M
14.36%182.15M
92.46M
56.45%361.32M
Operating cost
33.19%103.78M
11.98%338.51M
13.20%240.12M
16.60%149.34M
17.16%77.92M
10.00%302.3M
12.96%212.12M
4.75%128.08M
45.40%66.5M
69.08%274.81M
Operating tax surcharges
66.97%521.75K
-25.27%1.24M
-26.84%915.16K
-28.30%555.13K
-23.49%312.47K
-5.98%1.66M
-8.49%1.25M
-26.63%774.29K
--408.41K
94.25%1.77M
Operating expense
24.22%3.18M
58.85%12.9M
76.95%8.89M
104.56%5.52M
68.35%2.56M
54.88%8.12M
44.02%5.02M
15.41%2.7M
26.00%1.52M
26.35%5.24M
Administration expense
21.04%16.11M
-15.77%60.69M
-22.93%43.89M
-29.25%28.82M
-6.91%13.31M
24.76%72.05M
35.99%56.94M
51.36%40.74M
17.60%14.3M
39.82%57.75M
Financial expense
92.84%454.45K
92.08%-584.6K
55.44%-3.14M
22.33%-3.19M
-86.52%235.67K
-260.10%-7.38M
-494.75%-7.05M
-449.20%-4.11M
232.99%1.75M
-54.96%4.61M
-Interest expense (Financial expense)
130.56%2.41M
13.97%5.46M
-19.27%2.94M
-17.18%2.03M
-17.27%1.05M
89.29%4.79M
134.62%3.64M
252.33%2.45M
--1.26M
108.27%2.53M
-Interest Income (Financial expense)
76.32%-724.22K
-91.64%-5.53M
-857.76%-4.16M
-1,698.18%-3.52M
-4,030.13%-3.06M
-366.43%-2.88M
21.85%-434.71K
59.90%-195.68K
---74.05K
-77.43%-618.28K
Research and development
10.93%11.27M
14.34%37.34M
27.95%28.72M
38.04%19.28M
27.44%10.16M
90.46%32.65M
137.38%22.45M
152.52%13.97M
259.99%7.97M
44.92%17.14M
Credit Impairment Loss
-1,289.62%-795.77K
-208.10%-273.14K
-146.85%-151.34K
496.16%1.01M
-89.10%66.89K
110.25%252.66K
120.15%323.02K
109.33%168.73K
--613.63K
-409.54%-2.47M
Asset Impairment Loss
338.62%3.26M
-458.93%-12.09M
-50.42%-2.41M
3.98%-2.01M
12.55%-1.37M
-4.98%-2.16M
30.41%-1.6M
7.44%-2.09M
---1.56M
14.15%-2.06M
Other net revenue
1,226.30%6.36M
-164.76%-2.18M
167.16%1.67M
-25.57%-555.47K
323.51%479.89K
1,580.07%3.37M
134.37%625.16K
86.75%-442.35K
-214.71K
-106.98%-227.42K
Fair value change income
32.56%1.19M
5,716.89%5.58M
1,568.97%2.36M
-1,110.18%-2.99M
327.83%901.4K
-124.98%-99.35K
-127.40%-160.46K
-156.39%-246.76K
---395.65K
--397.68K
Invest income
320.44%1.94M
4.17%628.46K
21.08%726.01K
539.55%3.02M
1.50%461.08K
-66.52%603.32K
32.29%599.62K
57,745.02%471.45K
--454.25K
8.15%1.8M
-Including: Investment income associates
----
----
----
----
----
101.78%28.89
----
189.50%732.01
---597.33
-2.11%-1.62K
Asset deal income
----
--5.8K
--5.8K
--3.02K
--3.02K
----
----
----
----
--46.68K
Other revenue
85.95%768.29K
-16.79%3.97M
-22.12%1.14M
-66.88%416.43K
-38.76%413.17K
132.52%4.77M
40.07%1.46M
328.12%1.26M
--674.63K
-35.81%2.05M
Operating profit
-89.84%1.76M
-48.60%37.44M
17.79%49.49M
58.00%36.77M
49.19%17.37M
-15.95%72.85M
-11.40%42.02M
-13.20%23.27M
-14.34%11.64M
56.74%86.66M
Add:Non operating Income
1,877.39%121.61K
-87.22%26.28K
-96.72%6.75K
-91.65%6.75K
-91.89%6.15K
261.55%205.67K
884.73%205.67K
334.85%80.88K
--75.83K
-79.38%56.89K
Less:Non operating expense
-79.24%28.45K
446.89%707.82K
579.52%502.02K
414.69%279.58K
743.74%137.02K
-73.52%129.43K
-53.86%73.88K
-41.42%54.32K
--16.24K
38.80%488.79K
Total profit
-89.22%1.86M
-49.59%36.76M
16.25%49M
56.65%36.5M
47.31%17.24M
-15.44%72.92M
-10.86%42.15M
-12.86%23.3M
-13.53%11.7M
56.17%86.23M
Less:Income tax cost
-192.27%-1.81M
-114.91%-856.47K
-22.92%3.07M
29.93%3.61M
49.51%1.96M
-54.60%5.75M
-44.92%3.98M
-34.82%2.78M
--1.31M
93.99%12.66M
Net profit
-75.99%3.67M
-44.00%37.62M
20.33%45.93M
60.26%32.89M
47.03%15.28M
-8.70%67.18M
-4.72%38.17M
-8.70%20.52M
-6.81%10.39M
51.11%73.58M
Net profit from continuing operation
-75.99%3.67M
-44.00%37.62M
20.33%45.93M
60.26%32.89M
47.03%15.28M
-8.70%67.18M
-4.72%38.17M
-8.70%20.52M
--10.39M
51.11%73.58M
Net profit of parent company owners
-75.99%3.67M
-44.00%37.62M
20.33%45.93M
60.26%32.89M
47.03%15.28M
-8.70%67.18M
-4.72%38.17M
-8.70%20.52M
-6.81%10.39M
51.11%73.58M
Earning per share
Basic earning per share
-78.57%0.03
-55.70%0.35
-9.46%0.4268
19.23%0.31
-22.22%0.14
-38.28%0.79
-32.66%0.4714
-33.33%0.26
--0.18
48.84%1.28
Diluted earning per share
-78.57%0.03
-55.70%0.35
-9.46%0.4268
19.23%0.31
-22.22%0.14
-38.28%0.79
-32.66%0.4714
-33.33%0.26
--0.18
48.84%1.28
Other composite income
371.96%82.46K
250.87%69.91K
161.81%82.46K
62.30%82.46K
-112.84%-30.32K
157.91%19.92K
161.03%31.5K
50.81K
236.21K
Other composite income of parent company owners
----
371.96%82.46K
250.87%69.91K
161.81%82.46K
62.30%82.46K
-112.84%-30.32K
157.91%19.92K
161.03%31.5K
--50.81K
--236.21K
Total composite income
-76.12%3.67M
-43.85%37.7M
20.45%46M
60.42%32.97M
47.10%15.36M
-9.03%67.15M
-4.59%38.19M
-8.35%20.55M
10.44M
51.59%73.81M
Total composite income of parent company owners
-76.12%3.67M
-43.85%37.7M
20.45%46M
60.42%32.97M
47.10%15.36M
-9.03%67.15M
-4.59%38.19M
-8.35%20.55M
--10.44M
51.59%73.81M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 7.69%130.73M2.26%489.72M10.56%367.21M15.44%237.66M16.37%121.39M6.84%478.88M12.58%332.13M8.67%205.87M33.00%104.31M58.39%448.21M
Operating revenue 7.69%130.73M2.26%489.72M10.56%367.21M15.44%237.66M16.37%121.39M6.84%478.88M12.58%332.13M8.67%205.87M33.00%104.31M58.39%448.21M
Other operating revenue ----36.64%9.24M----427.56%8.54M----281.02%6.76M----170.43%1.62M-----60.46%1.77M
Total operating cost 29.49%135.33M9.94%450.09M9.86%319.39M9.98%200.33M13.03%104.5M13.31%409.4M18.30%290.74M14.36%182.15M92.46M56.45%361.32M
Operating cost 33.19%103.78M11.98%338.51M13.20%240.12M16.60%149.34M17.16%77.92M10.00%302.3M12.96%212.12M4.75%128.08M45.40%66.5M69.08%274.81M
Operating tax surcharges 66.97%521.75K-25.27%1.24M-26.84%915.16K-28.30%555.13K-23.49%312.47K-5.98%1.66M-8.49%1.25M-26.63%774.29K--408.41K94.25%1.77M
Operating expense 24.22%3.18M58.85%12.9M76.95%8.89M104.56%5.52M68.35%2.56M54.88%8.12M44.02%5.02M15.41%2.7M26.00%1.52M26.35%5.24M
Administration expense 21.04%16.11M-15.77%60.69M-22.93%43.89M-29.25%28.82M-6.91%13.31M24.76%72.05M35.99%56.94M51.36%40.74M17.60%14.3M39.82%57.75M
Financial expense 92.84%454.45K92.08%-584.6K55.44%-3.14M22.33%-3.19M-86.52%235.67K-260.10%-7.38M-494.75%-7.05M-449.20%-4.11M232.99%1.75M-54.96%4.61M
-Interest expense (Financial expense) 130.56%2.41M13.97%5.46M-19.27%2.94M-17.18%2.03M-17.27%1.05M89.29%4.79M134.62%3.64M252.33%2.45M--1.26M108.27%2.53M
-Interest Income (Financial expense) 76.32%-724.22K-91.64%-5.53M-857.76%-4.16M-1,698.18%-3.52M-4,030.13%-3.06M-366.43%-2.88M21.85%-434.71K59.90%-195.68K---74.05K-77.43%-618.28K
Research and development 10.93%11.27M14.34%37.34M27.95%28.72M38.04%19.28M27.44%10.16M90.46%32.65M137.38%22.45M152.52%13.97M259.99%7.97M44.92%17.14M
Credit Impairment Loss -1,289.62%-795.77K-208.10%-273.14K-146.85%-151.34K496.16%1.01M-89.10%66.89K110.25%252.66K120.15%323.02K109.33%168.73K--613.63K-409.54%-2.47M
Asset Impairment Loss 338.62%3.26M-458.93%-12.09M-50.42%-2.41M3.98%-2.01M12.55%-1.37M-4.98%-2.16M30.41%-1.6M7.44%-2.09M---1.56M14.15%-2.06M
Other net revenue 1,226.30%6.36M-164.76%-2.18M167.16%1.67M-25.57%-555.47K323.51%479.89K1,580.07%3.37M134.37%625.16K86.75%-442.35K-214.71K-106.98%-227.42K
Fair value change income 32.56%1.19M5,716.89%5.58M1,568.97%2.36M-1,110.18%-2.99M327.83%901.4K-124.98%-99.35K-127.40%-160.46K-156.39%-246.76K---395.65K--397.68K
Invest income 320.44%1.94M4.17%628.46K21.08%726.01K539.55%3.02M1.50%461.08K-66.52%603.32K32.29%599.62K57,745.02%471.45K--454.25K8.15%1.8M
-Including: Investment income associates --------------------101.78%28.89----189.50%732.01---597.33-2.11%-1.62K
Asset deal income ------5.8K--5.8K--3.02K--3.02K------------------46.68K
Other revenue 85.95%768.29K-16.79%3.97M-22.12%1.14M-66.88%416.43K-38.76%413.17K132.52%4.77M40.07%1.46M328.12%1.26M--674.63K-35.81%2.05M
Operating profit -89.84%1.76M-48.60%37.44M17.79%49.49M58.00%36.77M49.19%17.37M-15.95%72.85M-11.40%42.02M-13.20%23.27M-14.34%11.64M56.74%86.66M
Add:Non operating Income 1,877.39%121.61K-87.22%26.28K-96.72%6.75K-91.65%6.75K-91.89%6.15K261.55%205.67K884.73%205.67K334.85%80.88K--75.83K-79.38%56.89K
Less:Non operating expense -79.24%28.45K446.89%707.82K579.52%502.02K414.69%279.58K743.74%137.02K-73.52%129.43K-53.86%73.88K-41.42%54.32K--16.24K38.80%488.79K
Total profit -89.22%1.86M-49.59%36.76M16.25%49M56.65%36.5M47.31%17.24M-15.44%72.92M-10.86%42.15M-12.86%23.3M-13.53%11.7M56.17%86.23M
Less:Income tax cost -192.27%-1.81M-114.91%-856.47K-22.92%3.07M29.93%3.61M49.51%1.96M-54.60%5.75M-44.92%3.98M-34.82%2.78M--1.31M93.99%12.66M
Net profit -75.99%3.67M-44.00%37.62M20.33%45.93M60.26%32.89M47.03%15.28M-8.70%67.18M-4.72%38.17M-8.70%20.52M-6.81%10.39M51.11%73.58M
Net profit from continuing operation -75.99%3.67M-44.00%37.62M20.33%45.93M60.26%32.89M47.03%15.28M-8.70%67.18M-4.72%38.17M-8.70%20.52M--10.39M51.11%73.58M
Net profit of parent company owners -75.99%3.67M-44.00%37.62M20.33%45.93M60.26%32.89M47.03%15.28M-8.70%67.18M-4.72%38.17M-8.70%20.52M-6.81%10.39M51.11%73.58M
Earning per share
Basic earning per share -78.57%0.03-55.70%0.35-9.46%0.426819.23%0.31-22.22%0.14-38.28%0.79-32.66%0.4714-33.33%0.26--0.1848.84%1.28
Diluted earning per share -78.57%0.03-55.70%0.35-9.46%0.426819.23%0.31-22.22%0.14-38.28%0.79-32.66%0.4714-33.33%0.26--0.1848.84%1.28
Other composite income 371.96%82.46K250.87%69.91K161.81%82.46K62.30%82.46K-112.84%-30.32K157.91%19.92K161.03%31.5K50.81K236.21K
Other composite income of parent company owners ----371.96%82.46K250.87%69.91K161.81%82.46K62.30%82.46K-112.84%-30.32K157.91%19.92K161.03%31.5K--50.81K--236.21K
Total composite income -76.12%3.67M-43.85%37.7M20.45%46M60.42%32.97M47.10%15.36M-9.03%67.15M-4.59%38.19M-8.35%20.55M10.44M51.59%73.81M
Total composite income of parent company owners -76.12%3.67M-43.85%37.7M20.45%46M60.42%32.97M47.10%15.36M-9.03%67.15M-4.59%38.19M-8.35%20.55M--10.44M51.59%73.81M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg